Issue 6, 2018

Antitumor effects of melanin from Lachnum YM226 and its derivative in H22 tumor-bearing mice

Abstract

In the present study, we investigated the anti-tumor activities of the intracellular homogeneous melanin (LM) of Lachnum YM226 and its derivative (ALM) on liver cancer using murine H22 hepatocarcinoma model. The results showed that LM and ALM (50 and 200 mg kg−1) could effectively inhibit tumor growth of H22 tumour-bearing mice. The body weight, liver, spleen and thymus indices also improved in the LM and ALM treated groups. Moreover, the levels of alanine aminotransferase (ALT), aspartate aminotransaminase (AST), alkaline phosphatase (ALP), creatinine (CRE), blood urea nitrogen (BUN) and uric acid (UA) were lowered. Serum cytokines of interleukin-2 (IL-2), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) were increased on LM and ALM administration, while LM and ALM significantly decreased the vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) levels. The H&E staining indicated that LM and ALM exhibited antitumor activity in vivo by promoting apoptosis and inhibiting angiogenesis. The anti-tumor effect of ALM was more significant than that of LM for the same dose. In summary, the findings demonstrated that LM and ALM might be promising candidates for the prevention and treatment of HCC.

Graphical abstract: Antitumor effects of melanin from Lachnum YM226 and its derivative in H22 tumor-bearing mice

Supplementary files

Article information

Article type
Research Article
Submitted
20 Jan 2018
Accepted
08 May 2018
First published
16 May 2018

Med. Chem. Commun., 2018,9, 1059-1068

Antitumor effects of melanin from Lachnum YM226 and its derivative in H22 tumor-bearing mice

F. Shi, J. Li, Z. Ye, L. Yang, T. Chen, X. Chen and M. Ye, Med. Chem. Commun., 2018, 9, 1059 DOI: 10.1039/C8MD00035B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements